What Is a GLP-1 Weight Loss Programme?
A GLP-1 weight loss programme is a structured medical intervention that uses glucagon-like peptide-1 (GLP-1) receptor agonist medications — such as Semaglutide (Ozempic/Wegovy) or Tirzepatide (Mounjaro) — alongside diet counselling, metabolic monitoring, and regular physician reviews to help patients achieve meaningful, sustained weight loss.
Unlike over-the-counter diet supplements or generic slimming clinics, a proper GLP-1 programme begins with a thorough medical evaluation: blood tests, cardiovascular screening, HbA1c, fasting insulin, thyroid function, liver enzymes, and body composition analysis. The medication dose is then titrated gradually — starting low and moving up only when it is safe and well-tolerated.
The 'programme' aspect is critical. GLP-1 medications are powerful tools, but they work best when paired with nutritional guidance, physical activity support, and a physician who understands your metabolic history. Without that structure, patients risk poor dosing, unmanaged side effects, or weight regain once medication stops.